Bentham Science Logo

Track Your Manuscript:


Current Cancer Drug Targets

Volume 21, 11 Issues, 2021
ISSN: 1873-5576 (Online)
ISSN: 1568-0096 (Print)
This journal supports open access

Contents

Current Cancer Drug Targets, Volume 17 - Number 9



Review Article

Stem Cell Transplantation in Multiple Myeloma

, 17(9): 769 - 781

Massimo Offidani, Silvia Gentili, Francesca Gay, Elena Aghemo, Laura Maracci, Laura Corvatta and Antonio Palumbo*


DOI: 10.2174/1568009616666160920090236




Review Article

Multiple Myeloma and the Immune Microenvironment

, 17(9): 806 - 818

Yawara Kawano, Aldo. M. Roccaro, Irene M. Ghobrial* and Jamil Azzi*


DOI: 10.2174/1568009617666170214102301



Review Article

Immunomodulatory Activity of MicroRNAs: Potential Implications for Multiple Myeloma Treatment

, 17(9): 819 - 838

Cirino Botta, Maria Cuce, Daniele Caracciolo, Lucia Fiorillo, Pierosandro Tagliaferri and Pierfrancesco Tassone*


DOI: 10.2174/1568009617666170330154756



Review Article

Coinhibitory Molecule PD-1 as a Therapeutic Target in the Microenvironment of Multiple Myeloma

, 17(9): 839 - 845

Djordje Atanackovic, Tim Luetkens, Sabari Radhakrishnan and Nicolaus Kroger*


DOI: 10.2174/1568009617666170906170348



Review Article




Editor-in-Chief

Ruiwen Zhang
Center for Drug Discovery
University of Houston
3455 Cullen Blvd.
Houston, TX 77204
(USA)
View Full Editorial Board

COPE Compliant

Cope Logo

Journal History

Current Cancer Drug Targets was launched in 2001. Dr. Ruiwen Zhang serves as the Editor-in-Chief of the journal.

Advertisement

Oct-2021-ban

Related Journals

Related eBooks

eBooks Catalog